Helicobacter pylori disrupts gastric mucosal homeostasis by stimulating macrophages to secrete CCL3

Yan-Fei Wei1, Xue Li1, Meng-Ran Zhao1,2

  • 1Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.

Abstract

Insights

Helicobacter pylori infection triggers macrophages to release CCL3, a key factor in damaging gastric epithelial tight junctions via P38 phosphorylation, offering a new insight into H. pylori gastritis.

Area of Science:

  • Gastroenterology
  • Immunology
  • Cell Biology

Background:

  • Helicobacter pylori (H. pylori) is a primary cause of gastritis, damaging the gastric lining.
  • H. pylori interacts with macrophages, leading to inflammatory factor secretion and chronic mucosal damage.

Purpose of the Study:

  • To investigate the mechanism of gastric mucosal injury induced by macrophage-secreted inflammatory factors in H. pylori infection.
  • To identify specific inflammatory factors and pathways involved in H. pylori-related gastritis.

Main Methods:

  • Detected CCL3 expression and secretion in H. pylori-infected macrophages using RT-qPCR, Western blot, and ELISA.
  • Assessed the impact of H. pylori-infected macrophage medium and CCL3 on gastric epithelial cell tight junctions and proliferation/apoptosis.
  • Utilized dual-luciferase reporter and ChIP assays to identify CCL3 transcription factors and the JAK1-STAT1 pathway.
  • Analyzed gastric mucosal inflammation and CCL3 expression in mice via H&E staining and immunohistochemistry.

Main Results:

  • H. pylori infection increased macrophage secretion of CCL3.
  • CCL3 and H. pylori-infected macrophage medium disrupted gastric epithelial tight junctions, an effect reversed by CCL3 inhibition.
  • CCL3 induced P38 phosphorylation, contributing to tight junction disruption, with JAK1-STAT1 identified as the pathway regulating CCL3 transcription.
  • In vivo, CCL3 exacerbated gastric mucosal injury and inflammation in mice.

Conclusions:

  • H. pylori infection stimulates macrophages to secrete CCL3 through the JAK1-STAT1 pathway.
  • CCL3 damages gastric epithelial tight junctions by phosphorylating P38.
  • This pathway represents a novel mechanism in H. pylori-associated gastritis pathogenesis.

Related Concept Videos

Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
634
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
572
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
320
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
382
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
371
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
399